210 related articles for article (PubMed ID: 36334939)
1. Skin Cancer in Solid Organ Transplant Recipients: A Review for the Nondermatologist.
Berman H; Shimshak S; Reimer D; Brigham T; Hedges MS; Degesys C; Tolaymat L
Mayo Clin Proc; 2022 Dec; 97(12):2355-2368. PubMed ID: 36334939
[TBL] [Abstract][Full Text] [Related]
2. Skin Cancer Development Is Strongly Associated with Actinic Keratosis in Solid Organ Transplant Recipients: A Danish Cohort Study.
Wenande E; Togsverd-Bo K; Hastrup A; Lei U; Philipsen PA; Haedersdal M
Dermatology; 2023; 239(3):393-402. PubMed ID: 36731451
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
4. Overview on non-melanoma skin cancers in solid organ transplant recipients.
Forchetti G; Suppa M; Del Marmol V
G Ital Dermatol Venereol; 2014 Aug; 149(4):383-7. PubMed ID: 25068224
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
Schauder DM; Kim J; Nijhawan RI
JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
Cheng JY; Li FY; Ko CJ; Colegio OR
JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
[TBL] [Abstract][Full Text] [Related]
7. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
[TBL] [Abstract][Full Text] [Related]
9. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients.
O'Reilly Zwald F; Brown M
J Am Acad Dermatol; 2011 Aug; 65(2):253-261. PubMed ID: 21763561
[TBL] [Abstract][Full Text] [Related]
10. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin inhibitors for prolonged secondary prevention of nonmelanoma skin cancer in solid organ transplant recipients.
Gluck M; Hodak E; Davidovici B
Dermatol Ther; 2022 Aug; 35(8):e15649. PubMed ID: 35716099
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management.
Ferrándiz-Pulido C; Leiter U; Harwood C; Proby CM; Guthoff M; Scheel CH; Westhoff TH; Bouwes Bavinck JN; Meyer T; Nägeli MC; Del Marmol V; Lebbé C; Geusau A
Transplantation; 2023 Jul; 107(7):1452-1462. PubMed ID: 36706163
[TBL] [Abstract][Full Text] [Related]
13. Skin Cancers and Lung Transplant.
Wilken R; Carucci J; Stevenson ML
Semin Respir Crit Care Med; 2021 Jun; 42(3):483-496. PubMed ID: 34030209
[TBL] [Abstract][Full Text] [Related]
14. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
[TBL] [Abstract][Full Text] [Related]
15. External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort.
Gómez-Tomás Á; Bouwes Bavinck JN; Genders R; González-Cruz C; de Jong E; Arron S; García-Patos V; Ferrándiz-Pulido C
JAMA Dermatol; 2023 Jan; 159(1):29-36. PubMed ID: 36416811
[TBL] [Abstract][Full Text] [Related]
16. Skin Cancer in Non-White Solid Organ Transplant Recipients: Mayo Clinic Experience.
Zieman D; Heckman M; Brushaber D; Degesys C; Tolaymat L
South Med J; 2023 Oct; 116(10):839-844. PubMed ID: 37788820
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic options to decrease actinic keratosis and squamous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach.
Ritchie SA; Patel MJ; Miller SJ
Dermatol Surg; 2012 Oct; 38(10):1604-21. PubMed ID: 22646842
[TBL] [Abstract][Full Text] [Related]
18. Skin cancer in liver transplant recipients.
Otley CC; Pittelkow MR
Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
[TBL] [Abstract][Full Text] [Related]
19. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management.
Tessari G; Girolomoni G
Dermatol Surg; 2012 Oct; 38(10):1622-30. PubMed ID: 22805312
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous squamous cell carcinoma in the organ transplant recipient.
Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
